Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 177

    1.

    Statistical issues in toxicokinetic modeling: a bayesian perspective.

    Bernillon P, Bois FY.

    Environ Health Perspect. 2000 Oct;108 Suppl 5:883-93.PMID: 11035998 [PubMed - indexed for MEDLINE]Related articles

    2.

    Bayesian analysis of physiologically based toxicokinetic and toxicodynamic models.

    Hack CE.

    Toxicology. 2006 Apr 17;221(2-3):241-8. Epub 2006 Feb 8.PMID: 16466842 [PubMed - indexed for MEDLINE]Related articles

    3.

    The Bayesian population approach to physiological toxicokinetic-toxicodynamic models--an example using the MCSim software.

    Jonsson F, Johanson G.

    Toxicol Lett. 2003 Feb 18;138(1-2):143-50. Review.PMID: 12559698 [PubMed - indexed for MEDLINE]Related articles

    4.

    Probabilistic framework for the estimation of the adult and child toxicokinetic intraspecies uncertainty factors.

    Pelekis M, Nicolich MJ, Gauthier JS.

    Risk Anal. 2003 Dec;23(6):1239-55.PMID: 14641898 [PubMed - indexed for MEDLINE]Related articles

    5.

    Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice.

    Marino DJ, Clewell HJ, Gentry PR, Covington TR, Hack CE, David RM, Morgott DA.

    Regul Toxicol Pharmacol. 2006 Jun;45(1):44-54. Epub 2006 Jan 25.PMID: 16442684 [PubMed - indexed for MEDLINE]Related articles

    6.

    Analysis of PBPK models for risk characterization.

    Bois FY.

    Ann N Y Acad Sci. 1999;895:317-37.PMID: 10676425 [PubMed - indexed for MEDLINE]Related articles

    7.

    Physiologically based modeling of the inhalation kinetics of styrene in humans using a bayesian population approach.

    Jonsson F, Johanson G.

    Toxicol Appl Pharmacol. 2002 Feb 15;179(1):35-49.PMID: 11884235 [PubMed - indexed for MEDLINE]Related articles

    8.

    Computational toxicology of chloroform: reverse dosimetry using Bayesian inference, Markov chain Monte Carlo simulation, and human biomonitoring data.

    Lyons MA, Yang RS, Mayeno AN, Reisfeld B.

    Environ Health Perspect. 2008 Aug;116(8):1040-6. Erratum in: Environ Health Perspect. 2008 Aug;116(8):1046. PMID: 18709138 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Towards quantitative uncertainty assessment for cancer risks: central estimates and probability distributions of risk in dose-response modeling.

    Kopylev L, Chen C, White P.

    Regul Toxicol Pharmacol. 2007 Dec;49(3):203-7. Epub 2007 Aug 24. Review.PMID: 17905499 [PubMed - indexed for MEDLINE]Related articles

    10.

    Projection of cancer risks from the Japanese atomic bomb survivors to the England and Wales population taking into account uncertainty in risk parameters.

    Little MP, Deltour I, Richardson S.

    Radiat Environ Biophys. 2000 Dec;39(4):241-52. Erratum in: Radiat Environ Biophys 2001 Sep;40(3):236. PMID: 11200968 [PubMed - indexed for MEDLINE]Related articles

    11.

    Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach.

    Yokley K, Tran HT, Pekari K, Rappaport S, Riihimaki V, Rothman N, Waidyanatha S, Schlosser PM.

    Risk Anal. 2006 Aug;26(4):925-43.PMID: 16948686 [PubMed - indexed for MEDLINE]Related articles

    12.

    Probabilistic dose-response modeling: case study using dichloromethane PBPK model results.

    Marino DJ, Starr TB.

    Regul Toxicol Pharmacol. 2007 Dec;49(3):285-300. Epub 2007 Aug 29.PMID: 17949874 [PubMed - indexed for MEDLINE]Related articles

    13.

    PBPK models in risk assessment--A focus on chloroprene.

    DeWoskin RS.

    Chem Biol Interact. 2007 Mar 20;166(1-3):352-9. Epub 2007 Feb 8.PMID: 17324392 [PubMed - indexed for MEDLINE]Related articles

    14.

    Sources, pathways, and relative risks of contaminants in surface water and groundwater: a perspective prepared for the Walkerton inquiry.

    Ritter L, Solomon K, Sibley P, Hall K, Keen P, Mattu G, Linton B.

    J Toxicol Environ Health A. 2002 Jan 11;65(1):1-142. Review.PMID: 11809004 [PubMed - indexed for MEDLINE]Related articles

    15.

    Physiologically-based pharmacokinetic and toxicokinetic models in cancer risk assessment.

    Krishnan K, Johanson G.

    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2005;23(1):31-53. Review.PMID: 16291521 [PubMed - indexed for MEDLINE]Related articles

    16.

    Determination of a site-specific reference dose for methylmercury for fish-eating populations.

    Shipp AM, Gentry PR, Lawrence G, Van Landingham C, Covington T, Clewell HJ, Gribben K, Crump K.

    Toxicol Ind Health. 2000 Nov;16(9-10):335-438. Review.PMID: 11762928 [PubMed - indexed for MEDLINE]Related articles

    17.

    Bayesian population analysis of a washin-washout physiologically based pharmacokinetic model for acetone.

    Mörk AK, Jonsson F, Johanson G.

    Toxicol Appl Pharmacol. 2009 Nov 1;240(3):423-32. Epub 2009 Aug 4.PMID: 19660484 [PubMed - indexed for MEDLINE]Related articles

    18.

    Bayesian calibration of a physiologically based pharmacokinetic/pharmacodynamic model of carbaryl cholinesterase inhibition.

    Nong A, Tan YM, Krolski ME, Wang J, Lunchick C, Conolly RB, Clewell HJ 3rd.

    J Toxicol Environ Health A. 2008;71(20):1363-81.PMID: 18704829 [PubMed - indexed for MEDLINE]Related articles

    19.

    Bayesian ranking of sites for engineering safety improvements: decision parameter, treatability concept, statistical criterion, and spatial dependence.

    Miaou SP, Song JJ.

    Accid Anal Prev. 2005 Jul;37(4):699-720. Epub 2005 Apr 12. Review.PMID: 15949462 [PubMed - indexed for MEDLINE]Related articles

    20.

    Bayesian modeling of exposure and airflow using two-zone models.

    Zhang Y, Banerjee S, Yang R, Lungu C, Ramachandran G.

    Ann Occup Hyg. 2009 Jun;53(4):409-24. Epub 2009 Apr 29.PMID: 19403840 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data